TRX — Tissue Regenix Share News
0.000.00%
HealthcareSpeculativeMicro Cap
- £5.18m
- £12.00m
- $28.65m
New sports medicine product launch
Interim results
Exercise of Options and Total Voting Rights
Notice of interim results
Brief: Tissue Regenix Group Says Trading In First Half 2023 Was Strong & In Line With Board's Expectations
Half-Year Trading Update
Brief: Tissue Regenix Announces Distribution Agreement For Orthopure® XT In UK
Distribution agreement for OrthoPure® XT in the UK
Brief: Tissue Regenix Group Signs Distribution Agreement With Australian Allografts
Distribution agreement with Australian Allografts
Holding(s) in Company
Brief: Tissue Regenix Says On 4 April CEO Daniel Lee, Purchased 1.4 Million Of Company's Shares
CEO and CFO Share Purchases
Holding(s) in Company
Brief: Tissue Regenix Group Reports Full Year Gross Profit of 11.26 Million USD
Final results for the year ended 31 December 2022
Notice of results and Investor presentation
Trading Update For 2022
Trading update for 2022